PROM1 and glioblastoma: Additionally, it was shown that treatment with carbon nanotubes conjugated with anti-CD133 monoclonal antibody followed by irradiation with near-infrared laser light can selectively target CD133+ GBM cells, and the photothermolysis caused by the nanotubes can kill the targeted cells [65].